시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 철 결핍성 빈혈 치료 시장 보고서(2025년)
Iron Deficiency Anemia Treatment Global Market Report 2025
상품코드 : 1760580
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

철 결핍성 빈혈 치료 시장 규모는 향후 수 년간 급성장이 예상될 예정입니다. 예측 기간의 예상 성장은 연구 개발에 대한 투자 증가, 임신과 관련된 위험 증가, 영양 결핍 증가, 의료 인식 제고, 철분 결핍 빈혈의 지속적인 유병률 등 여러 요인에 기인할 수 있습니다. 예측 기간 중에 주목해야 할 주요 동향으로는 웨어러블 헤모글로빈 모니터의 개발, 환자 채팅봇에 의한 지원, 철 흡수 촉진제의 도입, 원격 모니터링 플랫폼의 확대, 신경인지 모니터링의 진전 등을 들 수 있습니다.

만성 신장병(CKD)의 유병률 증가는 철 결핍성 빈혈 치료 시장의 확대를 촉진할 것으로 예측됩니다. 고혈당 상태가 오랫동안 지속되면 신장의 혈관에 손상을 주고 노폐물을 여과하는 기능이 손상됩니다. 만성 신장 질환(CKD)에서 에리트로포이에틴 생성 감소로 인해 발생하는 빈혈을 해결하여 신장 기능에 도움이 될 수 있습니다. 2024년 4월에 아스트라제네카가 발표한 보고서에 따르면, 2032년까지 만성 신장 질환이 미국, 브라질, 영국, 스페인, 독일, 네덜란드, 중국, 호주를 포함한 8개국에서 만성 신장병이 인구의 16.5%까지 병을 앓고 진행기 환자는 59.3%까지 증가할 것으로 예측되고 있습니다.

철 결핍성 빈혈 치료 시장의 주요 기업은 치료 효과, 안전성 및 환자 편의성을 향상시키기 위해 철제 주사와 같은 차세대 솔루션의 개발에 주력하고 있습니다. 진보를 보여주는 신규 또는 상당히 강화된 주사 철제 치료를 가리킵니다. 제2철을 사용하는 정맥주사철요법, 레드샷 FCM을 발표했습니다. 이 치료법은 빠른 철분 보충을 위한 고급 카복시말토스 제제, 아나필락시스 위험 감소, 빠른 교정을 위한 고용량 단일 주입 투여, 소아(1세 이상) 및 성인 환자에게 적용 가능성 등 몇 가지 주요 이점을 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장의 거시경제 시나리오 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나와 회복이 시장에 미치는 영향을 포함

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 : 경쟁 벤치마킹 대시보드

제33장 주요 기업 합병·인수(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가·부문과 전략

제36장 부록

SHW
영문 목차

영문목차

Iron deficiency anemia treatment encompasses the medical strategies and interventions designed to correct iron deficiency in the body. These treatments aim to replenish iron levels through iron supplements, dietary changes, or intravenous iron, addressing the underlying cause of the deficiency and relieving associated symptoms.

The main types of iron deficiency anemia treatment include medications, blood transfusions, and other therapies. Medications refer to drugs or substances used to treat, prevent, or manage conditions including iron deficiency anemia. These include various types of iron supplements such as ferrous sulfate, ferrous gluconate, ferrous fumarate, ferric hydroxide, sodium ferric gluconate, and iron carbohydrates. These treatments are used across different therapy areas such as inflammatory bowel disease, renal disorders, obstetrics and gynecology, congestive heart failure, oncology, and more. The treatments can be administered orally or via injection and are utilized in various settings, including hospitals, clinics, home care environments, and pharmacies.

The iron deficiency anemia treatment market research report is one of a series of new reports from The Business Research Company that provides iron deficiency anemia treatment market statistics, including iron deficiency anemia treatment industry global market size, regional shares, competitors with a iron deficiency anemia treatment market share, iron deficiency anemia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the iron deficiency anemia treatment industry. This iron deficiency anemia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The iron deficiency anemia treatment market size has grown rapidly in recent years. It will grow from $7.85 billion in 2024 to $8.89 billion in 2025 at a compound annual growth rate (CAGR) of 13.4%. The growth during the historic period can be attributed to several factors, including the expansion of awareness programs and initiatives, the aging baby boomer population, increasing nutritional deficiencies, a rise in anemia cases worldwide, and the growing number of women of reproductive age.

The iron deficiency anemia treatment market size is expected to see rapid growth in the next few years. It will grow to $14.54 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The projected growth in the forecast period can be attributed to several factors, including increased investments in research and development, rising risks associated with pregnancy, growing nutritional deficits, heightened healthcare awareness, and the continued prevalence of iron deficiency anemia. Key trends to watch in the forecast period include the development of wearable hemoglobin monitors, the use of patient chatbots for support, the introduction of iron absorption enhancers, the expansion of remote monitoring platforms, and advancements in neurocognitive monitoring.

The growing prevalence of chronic kidney disease (CKD) is expected to drive the expansion of the iron deficiency anemia treatment market. CKD involves the gradual decline of kidney function over time, and its rise can be linked to increasing diabetes rates. High blood sugar levels over extended periods can damage the kidneys' blood vessels, impairing their ability to filter waste. Iron deficiency anemia treatment can help improve oxygen delivery to tissues, reduce fatigue, and enhance quality of life. Additionally, it may aid kidney function by addressing anemia, which is often caused by reduced erythropoietin production in CKD. A report published by AstraZeneca in April 2024 forecasts that by 2032, chronic kidney disease will affect up to 16.5 percent of the population in eight countries including the United States, Brazil, the United Kingdom, Spain, Germany, the Netherlands, China, and Australia, with advanced stage cases expected to rise by up to 59.3 percent. This growing prevalence of CKD is fueling the demand for iron deficiency anemia treatments.

Leading companies in the iron deficiency anemia treatment market are focusing on the development of next-generation solutions, such as iron injections, to improve treatment effectiveness, safety, and patient convenience. Iron injection refers to a new or significantly enhanced injectable iron therapy, marking a significant advancement in the treatment of iron deficiency and iron deficiency anemia. For example, in March 2024, Cadila Pharmaceuticals, an India-based company, introduced Redshot FCM, an intravenous iron therapy that uses ferric carboxymaltose to treat iron deficiency anemia (IDA). This therapy offers several key benefits, including an advanced ferric carboxymaltose formulation for fast iron replenishment, low risk of anaphylaxis, high-dose single-infusion administration for quick correction, and applicability for both pediatric (ages 1 and above) and adult patients. It helps accelerate hemoglobin recovery and is particularly beneficial for high-risk groups, such as pregnant women and cancer patients, with superior tolerability.

In August 2022, CSL Limited, an Australia-based biotechnology company specializing in iron deficiency injectables, acquired Vifor Pharma for an undisclosed amount. This acquisition strengthens CSL's commitment to patient care and enhances its capacity to offer innovative treatments. Vifor Pharma is a Switzerland-based provider of intravenous iron therapies for treating iron deficiency anemia.

Major players in the iron deficiency anemia treatment market are Sanofi SA, Fresenius SE & Co. KGaA, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Daiichi Sankyo Company Limited, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories, Pharmascience Inc., American Regent Inc., PharmaNutra S.p.A., Rockwell Medical Inc., Keryx Biopharmaceuticals Inc., Akebia Therapeutics Inc., Pharmacosmos A/S, Pieris Pharmaceuticals Inc., AdvaCare Pharma USA LLC, Apotex Inc., and Shield Therapeutics plc.

North America was the largest region in the iron deficiency anemia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in iron deficiency anemia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the iron deficiency anemia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The iron deficiency anemia treatment market consists of revenues earned by entities by providing services such as dietary counseling, monitoring and follow-up care, customized treatment plans, and management of side effects. The market value includes the value of related goods sold by the service provider or included within the service offering. The iron deficiency anemia treatment market also includes sales of iron-fortified foods, iron infusion kits, liquid iron supplements, and iron-rich multivitamins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Iron Deficiency Anemia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on iron deficiency anemia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for iron deficiency anemia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The iron deficiency anemia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Iron Deficiency Anemia Treatment Market Characteristics

3. Iron Deficiency Anemia Treatment Market Trends And Strategies

4. Iron Deficiency Anemia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Iron Deficiency Anemia Treatment Growth Analysis And Strategic Analysis Framework

6. Iron Deficiency Anemia Treatment Market Segmentation

7. Iron Deficiency Anemia Treatment Market Regional And Country Analysis

8. Asia-Pacific Iron Deficiency Anemia Treatment Market

9. China Iron Deficiency Anemia Treatment Market

10. India Iron Deficiency Anemia Treatment Market

11. Japan Iron Deficiency Anemia Treatment Market

12. Australia Iron Deficiency Anemia Treatment Market

13. Indonesia Iron Deficiency Anemia Treatment Market

14. South Korea Iron Deficiency Anemia Treatment Market

15. Western Europe Iron Deficiency Anemia Treatment Market

16. UK Iron Deficiency Anemia Treatment Market

17. Germany Iron Deficiency Anemia Treatment Market

18. France Iron Deficiency Anemia Treatment Market

19. Italy Iron Deficiency Anemia Treatment Market

20. Spain Iron Deficiency Anemia Treatment Market

21. Eastern Europe Iron Deficiency Anemia Treatment Market

22. Russia Iron Deficiency Anemia Treatment Market

23. North America Iron Deficiency Anemia Treatment Market

24. USA Iron Deficiency Anemia Treatment Market

25. Canada Iron Deficiency Anemia Treatment Market

26. South America Iron Deficiency Anemia Treatment Market

27. Brazil Iron Deficiency Anemia Treatment Market

28. Middle East Iron Deficiency Anemia Treatment Market

29. Africa Iron Deficiency Anemia Treatment Market

30. Iron Deficiency Anemia Treatment Market Competitive Landscape And Company Profiles

31. Iron Deficiency Anemia Treatment Market Other Major And Innovative Companies

32. Global Iron Deficiency Anemia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Iron Deficiency Anemia Treatment Market

34. Recent Developments In The Iron Deficiency Anemia Treatment Market

35. Iron Deficiency Anemia Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기